Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.165 USD | +2.76% | +4.28% | -5.65% |
Mar. 25 | Poseida Therapeutics Appoints Syed Rizvi as Chief Medical Officer | MT |
Mar. 25 | Poseida Therapeutics, Inc Appoints Syed Rizvi as Chief Medical Officer Effective April 1, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.65% | 297M | |
+2.94% | 108B | |
+9.31% | 104B | |
+6.58% | 23.66B | |
-12.23% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-13.48% | 16.19B | |
+4.08% | 13.72B | |
+32.97% | 12.22B |
- Stock
- Equities
- Stock Poseida Therapeutics, Inc. - Nasdaq
- News Poseida Therapeutics, Inc.
- Cantor Fitzgerald Starts Poseida Therapeutics at Overweight with $24 Price Target